Inactivation of the Kinase Domain of CDK10 Prevents Tumor Growth in a Preclinical Model of Colorectal Cancer, and Is Accompanied by Downregulation of Bcl-2
- 1 October 2017
- journal article
- Published by American Association for Cancer Research (AACR) in Molecular Cancer Therapeutics
- Vol. 16 (10) , 2292-2303
Abstract
Cyclin-dependent kinase 10 (CDK10), a CDC2-related kinase, is highly expressed in colorectal cancer. Its role in the pathogenesis of colorectal cancer is unknown. This study examines the function of CDK10 in colorectal cancer, and demonstrates its role in suppressing apoptosis and in promoting tumor growth in vitro and in vivo. Modulation of CDK10 expression in colorectal cancer cell lines demonstrates that CDK10 promotes cell growth, reduces chemosensitivity and inhibits apoptosis by upregulating the expression of Bcl-2. This effect appears to depend on its kinase activity, as kinase-defective mutant colorectal cancer cell lines have an exaggerated apoptotic response and reduced proliferative capacity. In vivo, inhibiting CDK10 in colorectal cancer following intratumoral injections of lentivirus-mediated CDK10 siRNA in a patient-derived xenograft mouse model demonstrated its efficacy in suppressing tumor growth. Furthermore, using a tissue microarray of human colorectal cancer tissues, the potential for CDK10 to be a prognostic biomarker in colorectal cancer was explored. In tumors of individuals with colorectal cancer, high expression of CDK10 correlates with earlier relapse and shorter overall survival. The findings of this study indicate that CDK10 plays a role in the pathogenesis in colorectal cancer and may be a potential therapeutic target for treatment. Mol Cancer Ther; 16(10); 2292–303. ©2017 AACR.Keywords
All Related Versions
This publication has 40 references indexed in Scilit:
- A Kinase-Independent Function of CDK6 Links the Cell Cycle to Tumor AngiogenesisCancer Cell, 2013
- Comprehensive molecular characterization of human colon and rectal cancerNature, 2012
- Randomized phase II study of two schedules of flavopiridol given as timed sequential therapy with cytosine arabinoside and mitoxantrone for adults with newly diagnosed, poor-risk acute myelogenous leukemiaHaematologica, 2012
- Secreted protein acidic and rich in cysteine-induced cellular senescence in colorectal cancers in response to irinotecan is mediated by P53Carcinogenesis, 2010
- Lentivirus ProductionJournal of Visualized Experiments, 2009
- A structural perspective of CTD functionGenes & Development, 2005
- Alterations in Cell Cycle Genes in Early Stage Lung Adenocarcinoma Identified by Expression ProfilingCancer Biology & Therapy, 2003
- Cdk10, a Cdc2-related kinase, associates with the Ets2 transcription factor and modulates its transactivation activityOncogene, 2001
- Human CDK10 Gene IsoformsBiochemical and Biophysical Research Communications, 2000
- A genetic model for colorectal tumorigenesisCell, 1990